Centiva Capital, LP Sarepta Therapeutics, Inc. Call Options Transaction History

Centiva Capital, LP

  • $4.79 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$67.31 - $124.76 $168,275 - $311,900
2,500 Added 100.0%
5,000 $482,000
Q3 2023

Nov 14, 2023
BUY
$102.5 - $123.59 $256,250 - $308,975
2,500 New
2,500 $303,000
Q4 2022

Feb 14, 2023
BUY
$100.86 - $132.13 $504,300 - $660,650
5,000 Added 66.67%
12,500 $1.62 Million
Q3 2022

Nov 14, 2022
BUY
$75.71 - $119.24 $567,825 - $894,300
7,500 New
7,500 $829,000

Others Institutions Holding SRPT

# of Institutions
525
Shares Held
84.4M
Call Options Held
2.06M
Put Options Held
1.52M
View Full List

About Sarepta Therapeutics, Inc.

SRPT Quotes by TradingView
  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $9.96B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email